The test, which must be administered by a trained operator, demonstrates a high degree of accuracy.
NIH spending nearly $470 million on ‘long-haul COVID’ study
Sep 16, 2021
The goal is to uncover why some people have prolonged symptoms or develop new or returning symptoms after recovering from COVID-19.
FDA approves first drug meant to ease Alzheimer’s disease-llnked agitation
May 11, 2023
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo.
Adverse effects generally mild after BNT162b2 mRNA booster in over 60s
Apr 18, 2022
Thirty percent of those aged 60 years or older receiving a booster reported at least one adverse event; few sought medical attention.
Sleep problems linked to increased risk for stroke
Apr 06, 2023
The odds of stroke increased with short or long duration of sleep, impaired sleep quality, snoring, snorting and breathing cessation.
FDA approves topical treatment for molluscum contagiosum
Jul 24, 2023
Ycanth has been approved for adults and children older than 2 years.
Pfizer-BioNTech COVID-19 vaccine receives full FDA approval
Aug 23, 2021
The vaccine will now be marketed as Comirnaty and is fully approved for the prevention of COVID-19 in individuals 16 years and older.
Risk for Guillain-Barré syndrome up after Ad.26.COV2.S vaccination
Apr 26, 2022
An adjusted rate ratio of 20.56 was found in a head-to-head comparison of the Johnson & Johnson vaccine and the Pfizer-BioNTech and Moderna COVID-19 vaccines.
FDA panel recommends approval of Johnson & Johnson booster shot
Oct 15, 2021
The booster shot is recommended for anyone 18 years and older, to be given at least two months after the first dose.
Mounjaro approved for blood glucose control in type 2 diabetes
May 20, 2022
The once-weekly injection is approved as an addition to diet and exercise.